Plasma hsCRP level at 0, 4, 8 weeks
Showing 1 - 25 of >10,000
HIV Trial in Badalona (DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM), At least 24 weeks since
Completed
- HIV
- DNA.HTI 0.5mL at weeks 0, 4 and 8 + MVA.HTI 0.5mL at weeks 12 and 20 (DDDMM)
- +2 more
-
Badalona, Barcelona, SpainIrsiCaixa AIDS Research Institute, Hospital Universitari Germans
Apr 7, 2021
Obesity Associated Disorder Trial in Foshan (Treatment with Akkermansia muciniphila, Treatment with )
Recruiting
- Obesity Associated Disorder
- Treatment with Akkermansia muciniphila
- Treatment with placebo
-
Foshan, Guangdong, ChinaThe Seventh Affiliated Hospital of Southern Medical University
Feb 7, 2023
Diabetes Type 2 With Proteinuria, Diabetes, Type 2, Diabetes Trial (drug, device, diagnostic test, behavioral)
Not yet recruiting
- Diabetes Mellitus Type 2 With Proteinuria
- +12 more
- Empagliflozin 10 MG
- +6 more
- (no location specified)
Oct 17, 2023
Health, Subjective, Inflammatory Response, Adverse Effect Trial in Puerto Rico, United States (Cannabigerol)
Enrolling by invitation
- Health, Subjective
- +3 more
- Cannabigerol
-
Arlington, Texas
- +6 more
Feb 23, 2023
Androgenic Alopecia Trial in United States (Keravive by Hydrafacial Treatments)
Completed
- Androgenic Alopecia
- Keravive by Hydrafacial Treatments
-
Los Angeles, California
- +3 more
Oct 27, 2023
Vasomotor Symptoms Associated With Menopause, Hot Flashes Trial in Worldwide (Elinzanetant (BAY3427080), Placebo)
Active, not recruiting
- Vasomotor Symptoms Associated With Menopause
- Hot Flashes
- Elinzanetant (BAY3427080)
- Placebo
-
Birmingham, Alabama
- +98 more
Feb 2, 2023
Infections, Rotavirus Trial in Worldwide (PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine, Lyophilized
Completed
- Infections, Rotavirus
- PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine
- Lyophilized formulation of GSK's oral live attenuated HRV vaccine
-
Birmingham, Alabama
- +36 more
Feb 25, 2022
Resistance Training, Stroke, Arthroplasty, Replacement, Hip Trial in Taichung City (Isokinetic strengthening exercise, Isotonic
Recruiting
- Resistance Training
- +3 more
- Isokinetic strengthening exercise
- Isotonic strengthening exercise
-
Taichung City, TaiwanDepartment of Physical Medicine and Rehabilitation
Apr 25, 2022
Trauma Injury Trial in United Kingdom, United States (Cryoprecipitate, Red Blood Cells, Plasma)
Active, not recruiting
- Trauma Injury
- Cryoprecipitate
- +4 more
-
Houston, Texas
- +24 more
Jan 13, 2022
Crohn's Disease Trial (Vedolizumab IV, Placebo)
Not yet recruiting
- Crohn's Disease
- Vedolizumab IV
- Placebo
- (no location specified)
Apr 20, 2023
Knee Osteoarthritis Trial in Gujranwala (close kinetic chain exercises, open kinetic chain exercises)
Recruiting
- Knee Osteoarthritis
- close kinetic chain exercises
- open kinetic chain exercises
-
Gujrānwāla, Punjab, PakistanAl-Raee Trust Hospital
May 18, 2023
Iron Deficiency (Without Anemia), B12 Deficiency Vitamin Trial in Norwich (Recipes consumption, Hydroponic unit)
Enrolling by invitation
- Iron Deficiency (Without Anemia)
- B12 Deficiency Vitamin
- Recipes consumption
- Hydroponic unit
-
Norwich, United KingdomQuadram Institute Bioscience
Feb 27, 2023
Chronic Low-back Pain Trial (Hypnosis audio recordings)
Not yet recruiting
- Chronic Low-back Pain
- Hypnosis audio recordings
- (no location specified)
Sep 22, 2023
Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Wuhan (Colchicine 0.5 MG, Colchicine 0.375 MG, Colchicine
Not yet recruiting
- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Colchicine 0.5 MG
- +3 more
-
Wuhan, Hubei, ChinaDepartment of Cardiology, Union Hospital, Tongji Medical College
Oct 5, 2023
Cellulite Trial in Pasadena (Calcium Hydroxyapatite)
Active, not recruiting
- Cellulite
- Calcium Hydroxyapatite
-
Pasadena, CaliforniaK. Kay Durairaj, MD, FACS, A Medical Corporation
May 31, 2023
Type 1 Diabetes, Cardiovascular Diseases, Chronic Inflammation Trial in Hellerup (Colchicine 0.5 MG Oral Tablet, Placebo)
Not yet recruiting
- Type 1 Diabetes
- +2 more
- Colchicine 0.5 MG Oral Tablet
- Placebo
-
Hellerup, Capital Region, DenmarkCenter for Clinical Metabolic Research, Gentofte Hospital
Jul 7, 2023
Menopause Trial in Shatin (Modified Guizhi Fuling granules, Placebo)
Not yet recruiting
- Menopause
- Modified Guizhi Fuling granules
- Placebo
-
Shatin, Hong KongSchool of Chinese Medicine
Oct 4, 2023
Healthy Participants Trial in Cypress (Semaglutide J, Semaglutide C)
Recruiting
- Healthy Participants
- Semaglutide J
- Semaglutide C
-
Cypress, CaliforniaNovo Nordisk Investigational Site
Mar 28, 2023
Hyperlipidemias Trial in Belfast (Fenugreek Seed Tea, Black Tea)
Recruiting
- Hyperlipidemias
- Fenugreek Seed Tea
- Black Tea
-
Belfast, Northern Ireland, United Kingdom
- +1 more
May 5, 2023
Chronic Kidney Diseases, MDD Trial in Dallas, Seattle (drug, behavioral, other)
Recruiting
- Chronic Kidney Diseases
- Major Depressive Disorder
- Bupropion
- +3 more
-
Dallas, Texas
- +2 more
May 27, 2022
Osteoarthritis, Knee Trial in Nashville (PRP injection dose (<5 billion platelets), PRP injection dose (between 5 and <10
Suspended
- Osteoarthritis, Knee
- PRP injection dose (<5 billion platelets)
- +4 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 30, 2023
Chronic Periodontitis Trial in Pune (Dentifrice Paste)
Recruiting
- Chronic Periodontitis
- Dentifrice Paste
-
Pune, Maharashtra, IndiaDr. D Y Patil Dental College and Hospital, Pimpri, Pune
Sep 12, 2023
Plasma Concentration of Ceftazidime-Avibactam in Critically Ill
Recruiting
- Severe Sepsis
-
Hangzhou, Zhejiang, ChinaThe First Affiliated Hospital,College of Medicine,Zhejiang Unive
Jun 7, 2022